找化学品上960化工网!
960化工网

普伐他汀钠 | 81131-70-6

普伐他汀钠
Pravastatin sodium
81131-70-6
C23H36NaO7
447.517518997192
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:普伐他汀钠结构式
87561232
普伐他汀钠价格
简介
普伐他汀钠(Pravastatin sodium)可选择性地作用于合成胆固醇的主要脏器——肝和小肠,降低血清胆固醇值,改善血清脂质。主要从以下两个方面来发挥降脂作用。一是可逆性地抑制HMG-CoA还原酶活性,使细胞内胆固醇的量有一定程度的降低,导致细胞表面的低密度脂蛋白受体数增加,从而加强了由受体介导的低密度脂蛋白胆固醇(LDL-C)的分解代谢和血液中LDL-C的清除。二是通过抑制LDL-C的前体——极低密度脂蛋白胆固醇(VLDL-C)在肝内的合成,从而抑制LDL-C的生成。
名称和标识符
MDL MFCD00887601
InChIKey RNAREGLVKQKRSG-IYNICTALSA-N
Inchi 1S/C23H36O7.Na/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28;/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28);/t13-,14-,16+,17+,18+,19-,20-,22-;/m0./s1
SMILES C([C@H]1[C@@H](C)C=CC2[C@@H]1[C@H](C[C@@H](C=2)O)OC(=O)[C@@H](C)CC)C[C@@H](O)C[C@@H](O)CC(=O)O.[Na]
BRN 4836204
别名信息
- 中文别名 -
  • 普伐他汀钠
  • 1,2,6,7,8,8a-六氢-2-甲基-8-(2-甲基丁酰氧基)-1-萘-3',5',6-三羟基庚酸钠盐
  • Pravastatin Sodium 普伐他汀钠
  • 结合雌激素
  • 普伐他丁钠
  • 普伐他汀
  • 普伐他汀钠 USP标准品
  • 普伐他汀钠 标准品
  • 普伐他汀钠盐
  • 普伐他汀钠盐标准品
  • 普伐他汀钠,{1S-[1α(βS*,δS*),2α,6α,8β(R*),8aα]}-1,2,6,7,8,8a-六氢- 2- 甲基-8-(2-甲基-1-氧丁氧基)-β,δ,6-三羟基-1-萘庚酸钠盐
  • 普伐他汀钠(分析标准品)
- 英文别名 -
  • 3BETA-HYDROXYCOMPACTIN, NA
  • (BETA R,DELTA R,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8-[(2S)-2-METHYL-1-OXOBUTOXY]-1-NAPHTHALENEHEPTANOIC ACID MONOSODIUM SALT
  • (BETAR, DELTAR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA, DELTA,6-TRIHYDROXY-2-METHYL-8[(2S)-2-METHYL-1-OXOBUTOXYL]-1-NAPHTHALENEHEPTANOIC ACID SODIUM
  • (BETA-R,DELTA-R,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-BETA,DELTA,6-TRIHYDROXY-2-METHYL-8[(2S)-2-METHYL-1-OXOBUTOXYL]-1-NAPHTHALENEHEPTANOIC ACID NA
  • ELISOR
  • EPTASTATIN SODIUM
  • KOPOSTAT
  • MEVALOTIN
  • PRAVACHOL
  • PRAVASELECT
  • PRAVASTATIN SODIUM
  • PRAVASTATIN SODIUM SALT
  • 2-alpha,6-alpha,8-beta(r*),8a-alpha))-*
  • cs-514
  • epastatinsodium
  • lipostat
  • sq31000 utoxy)-beta,delta,6-trihydroxy-,monosodiumsalt,(1s-(1-alpha(beta-s*,delta-s
  • Pravastatin Sodium (US Pat 1981)
  • Pravastatin (sodium salt)
  • Pravastatin (sodium)
  • PRAVASTATIN SODIUM EP5
  • PRAVASTATIN SODIUM(RG)
  • (βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-β,,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
  • [1S-[1a(bS,dS),2a,6b,8b(R),8aa]]-1,2,6,7,8,8a-Hexahydro-b,d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic acid monosodium salt
  • CS-514 sodium
  • Pravastatin sodium
  • PRAVASTATIN SODIUM [EP MONOGRAPH]
  • PRAVASTATIN SODIUM [EP MONOGRAPH]
  • PRAVASTATIN SODIUM [EP MONOGRAPH]
  • PRAVASTATIN SODIUM [EP MONOGRAPH]
  • VWBQYTRBTXKKOG-IYNICTALSA-M
  • VWBQYTRBTXKKOG-IYNICTALSA-M
  • VWBQYTRBTXKKOG-IYNICTALSA-M
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1.ALPHA.(.BETA.S*,DS*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.))-
  • VWBQYTRBTXKKOG-IYNICTALSA-M
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1.ALPHA.(.BETA.S*,DS*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.))-
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1.ALPHA.(.BETA.S*,DS*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.))-
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1.ALPHA.(.BETA.S*,DS*),2.ALPHA.,6.ALPHA.,8.BETA.(R*),8A.ALPHA.))-
  • PRAVASTATIN SODIUM [VANDF]
  • PRAVASTATIN SODIUM [VANDF]
  • PRAVASTATIN SODIUM [VANDF]
  • Pravastatin sodium [USAN:USP:JAN]
  • PRAVASTATIN SODIUM [VANDF]
  • Pravastatin sodium [USAN:USP:JAN]
  • Sodium Salt, Pravastatin
  • Pravastatin sodium [USAN:USP:JAN]
  • Pravastatin sodium [USAN:USP:JAN]
  • Sodium Salt, Pravastatin
  • CS-514 Sodium
  • Sodium Salt, Pravastatin
  • Sodium Salt, Pravastatin
  • CS-514 Sodium
  • CS-514 Sodium
  • Pravacol
  • CS-514 Sodium
  • Pravacol
  • Pravacol
  • PRAVASTATIN SODIUM [ORANGE BOOK]
  • Pravacol
  • PRAVASTATIN SODIUM [ORANGE BOOK]
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • PRAVASTATIN SODIUM [ORANGE BOOK]
  • PRAVASTATIN SODIUM [ORANGE BOOK]
  • CRES Pravastatin
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • HY-B0165A
  • CRES Pravastatin
  • CRES Pravastatin
  • CRES Pravastatin
  • HY-B0165A
  • PRAVASTATIN SODIUM [WHO-DD]
  • HY-B0165A
  • HY-B0165A
  • PRAVASTATIN SODIUM [WHO-DD]
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
  • PRAVASTATIN SODIUM [WHO-DD]
  • PRAVASTATIN SODIUM [WHO-DD]
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
  • Pravaselect
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-
  • Pravaselect
  • Pravaselect
  • PRAVASTATIN SODIUM (USP-RS)
  • Pravaselect
  • PRAVASTATIN SODIUM (USP-RS)
  • PRAVASTATIN SODIUM (USP-RS)
  • hexahydronaphthalen-1-yl)heptanoate
  • hexahydronaphthalen-1-yl)heptanoate
  • PRAVASTATIN SODIUM (USP-RS)
  • NCGC00092370-01
  • hexahydronaphthalen-1-yl)heptanoate
  • hexahydronaphthalen-1-yl)heptanoate
  • NCGC00092370-01
  • Pravasin
  • NCGC00092370-01
  • Pravasin
  • PRAVASTATIN SODIUM [MI]
  • NCGC00092370-01
  • Pravasin
  • PRAVASTATIN SODIUM [MI]
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
  • PRAVASTATIN SODIUM [MI]
  • Pravasin
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
  • PRAVASTATIN SODIUM [MART.]
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
  • SQ 31000
  • PRAVASTATIN SODIUM [MI]
  • PRAVASTATIN SODIUM [MART.]
  • PRAVASTATIN SODIUM [MART.]
  • 81131-70-6
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-2-methyl-8-(2-methyl-1-oxobutoxy)-beta,delta,6-trihydroxy-, monosodium salt, (1S-(1-alpha(beta-S*,delta-S*),2-alpha,6-alpha,8-beta(R*),8a-alpha))-
  • SQ 31000
  • SQ 31000
  • Tox21_300270
  • PRAVASTATIN SODIUM [MART.]
  • 81131-70-6
  • 81131-70-6
  • Vasten
  • SQ 31000
  • Tox21_300270
  • PRAVASTATIN SODIUM (MART.)
  • Tox21_300270
  • 81131-70-6
  • Vasten
  • Aplactin
  • Tox21_300270
  • Vasten
  • PRAVASTATIN SODIUM (MART.)
  • PRAVASTATIN SODIUM (MART.)
  • Vasten
  • Pravastatin sodium- Bio-X
  • Aplactin
  • CS-2003
  • Aplactin
  • PRAVASTATIN SODIUM (MART.)
  • Pravastatin sodium- Bio-X
  • Pravastatin sodium- Bio-X
  • Aplactin
  • 3M8608UQ61
  • CS-2003
  • Pravastatin sodium- Bio-X
  • CS-2003
  • 3M8608UQ61
  • UNII-3M8608UQ61
  • CS-2003
  • 3M8608UQ61
  • PRAVASTATIN SODIUM (USP MONOGRAPH)
  • UNII-3M8608UQ61
  • UNII-3M8608UQ61
  • 3M8608UQ61
  • HMS3268L20
  • PRAVASTATIN SODIUM (USP MONOGRAPH)
  • UNII-3M8608UQ61
  • PRAVASTATIN SODIUM (USP MONOGRAPH)
  • DTXCID4027525
  • HMS3268L20
  • DTXCID4027525
  • HMS3268L20
  • PRAVASTATIN SODIUM (USP MONOGRAPH)
  • SQ-31,000
  • SQ-31,000
  • DTXCID4027525
  • (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
  • HMS3268L20
  • SQ-31,000
  • Bristacol
  • (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
  • DTXCID4027525
  • PRAVIGARD PAC COMPONENT PRAVASTATIN SODIUM
  • (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
  • Bristacol
  • SQ-31,000
  • Bristacol
  • Pralidon
  • PRAVIGARD PAC COMPONENT PRAVASTATIN SODIUM
  • (?R,?R,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-?,?,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid monosodium salt
  • PRAVIGARD PAC COMPONENT PRAVASTATIN SODIUM
  • Pralidon
  • HMS3413E20
  • Bristacol
  • Pralidon
  • HMS3413E20
  • Selektine
  • PRAVIGARD PAC COMPONENT PRAVASTATIN SODIUM
  • Selektine
  • PRAVASTATIN SODIUM COMPONENT OF PRAVIGARD PAC
  • HMS3413E20
  • Pralidon
  • PRAVASTATIN SODIUM COMPONENT OF PRAVIGARD PAC
  • AKOS015964902
  • HMS3413E20
  • Selektine
  • HMS2051P05
  • AKOS015964902
  • Selektine
  • PRAVASTATIN SODIUM COMPONENT OF PRAVIGARD PAC
  • HMS2051P05
  • Pravastatinsodium,(S)
  • PRAVASTATIN SODIUM COMPONENT OF PRAVIGARD PAC
  • AKOS015964902
  • Pravastatinsodium,(S)
  • AKOS015964902
  • Pravachol
  • HMS2051P05
  • Pravachol
  • HMS2051P05
  • Dehypotin protect
  • Pravastatinsodium,(S)
  • Dehypotin protect
  • Pravastatinsodium,(S)
  • PRAVASTATIN SODIUM (EP MONOGRAPH)
  • Pravachol
  • PRAVASTATIN SODIUM (EP MONOGRAPH)
  • Pravachol
  • Pravastatin sodium salt hydrate, >=98% (HPLC), powder
  • Dehypotin protect
  • Pravastatin sodium salt hydrate, >=98% (HPLC), powder
  • CAS-81131-70-6
  • Dehypotin protect
  • PRAVASTATIN SODIUM (EP MONOGRAPH)
  • CAS-81131-70-6
  • Monosodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((2S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • PRAVASTATIN SODIUM (EP MONOGRAPH)
  • Pravastatin sodium salt hydrate, >=98% (HPLC), powder
  • Monosodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((2S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • SQ-31000
  • Pravastatin sodium salt hydrate, >=98% (HPLC), powder
  • CAS-81131-70-6
  • SQ-31000
  • AMY40517
  • CAS-81131-70-6
  • Monosodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((2S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • AMY40517
  • SQ-31000
  • Monosodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((2S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • Lipostat
  • Lipostat
  • AMY40517
  • SQ-31000
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((2S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((2S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • Lipostat
  • AMY40517
  • sodium
  • (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • sodium
  • (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((2S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • Lipostat
  • CHEBI:8361
  • CHEBI:8361
  • NSC-759253
  • NSC-759253
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((2S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate
  • sodium
  • (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • Pravastatin sodium (JP17/USP)
  • CHEBI:8361
  • Pravastatin sodium (JP17/USP)
  • sodium
  • (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • CHEBI:8361
  • DTXSID6047525
  • DTXSID6047525
  • NSC-759253
  • NSC-759253
  • Pravastatin Natrium Mayrho Fer
  • Pravastatin Natrium Mayrho Fer
  • Pravastatin sodium (JP17/USP)
  • Pravastatin sodium (JP17/USP)
  • PRAVASTATIN SODIUM [JAN]
  • DTXSID6047525
  • PRAVASTATIN SODIUM [JAN]
  • 3-beta-Hydroxycompactin sodium salt
  • 3-beta-Hydroxycompactin sodium salt
  • DTXSID6047525
  • Pravastatin Natrium Mayrho Fer
  • PRAVASTATIN SODIUM [USP MONOGRAPH]
  • PRAVASTATIN SODIUM [USP MONOGRAPH]
  • Pravastatin Natrium Mayrho Fer
  • PRAVASTATIN SODIUM [JAN]
  • CS-0694887
  • CS-0694887
  • PRAVASTATIN SODIUM [JAN]
  • 3-beta-Hydroxycompactin sodium salt
  • CS-514
  • PRAVASTATIN SODIUM [USP MONOGRAPH]
  • 3-beta-Hydroxycompactin sodium salt
  • CS-514
  • Epastatin sodium
  • CS-0694887
  • Epastatin sodium
  • PRAVASTATIN SODIUM [USP MONOGRAPH]
  • CS-514
  • s3036
  • s3036
  • CS-0694887
  • BP164292
  • Epastatin sodium
  • BP164292
  • CS-514
  • Q27108059
  • Q27108059
  • Epastatin sodium
  • s3036
  • Vasen
  • Vasen
  • s3036
  • BP164292
  • NCGC00095183-01
  • NCGC00095183-01
  • BP164292
  • Q27108059
  • PRAVASTATIN SODIUM [USAN]
  • PRAVASTATIN SODIUM [USAN]
  • Q27108059
  • Vasen
  • P1796
  • P1796
  • NCGC00095183-01
  • Vasen
  • D00893
  • D00893
  • PRAVASTATIN SODIUM [USAN]
  • NCGC00095183-01
  • SCHEMBL3013
  • P1796
  • SCHEMBL3013
  • PRAVASTATIN SODIUM [USAN]
  • Sanaprav
  • D00893
  • Sanaprav
  • P1796
  • Liplat
  • SCHEMBL3013
  • D00893
  • Liplat
  • Tox21_111474
  • Sanaprav
  • SCHEMBL3013
  • Tox21_111474
  • AKOS015896504
  • Liplat
  • Sanaprav
  • NCGC00254232-01
  • AKOS015896504
  • Tox21_111474
  • Liplat
  • CCG-100926
  • AKOS015896504
  • NCGC00254232-01
  • NCGC00254232-01
  • SODIUM (+)-(betaR,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-beta,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • Tox21_111474
  • CCG-100926
  • Selipran
  • CCG-100926
  • AKOS015896504
  • SODIUM (+)-(betaR,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-beta,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • DRG-0319
  • NCGC00254232-01
  • SODIUM (+)-(betaR,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-beta,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • Selipran
  • CCG-100926
  • Lipidal
  • Selipran
  • SODIUM (+)-(betaR,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-beta,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • DRG-0319
  • Pravastatin, Sodium Salt
  • DRG-0319
  • Lipidal
  • Selipran
  • CHEMBL690
  • Lipidal
  • NC00176
  • Pravastatin, Sodium Salt
  • DRG-0319
  • Pravastatin, Sodium Salt
  • CHEMBL690
  • SODIUM (+)-(.BETA.R,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • CHEMBL690
  • Lipidal
  • NC00176
  • NC00176
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid, sodium salt
  • Pravastatin, Sodium Salt
  • SODIUM (+)-(.BETA.R,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • SODIUM (+)-(.BETA.R,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • Pravastatin Sodium Salt
  • CHEMBL690
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid, sodium salt
  • NC00176
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid, sodium salt
  • Liprevil
  • Pravastatin Sodium Salt
  • SODIUM (+)-(.BETA.R,DR,1S,2S,6S,8S,8AR)-1,2,6,7,8,8A-HEXAHYDRO-.BETA.,D,6,8-TETRAHYDROXY-2-METHYL-1-NAPHTHALENEHEPTANOATE, 8-((2S)-2-METHYLBUTYRATE)
  • Pravastatin Sodium Salt
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-beta,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1alpha(betaS*,DS*),2alpha,6alpha,8beta(R*),8Aalpha))-
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid, sodium salt
  • Liprevil
  • Liprevil
  • NSC 759253
  • Pravastatin Sodium Salt
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-beta,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1alpha(betaS*,DS*),2alpha,6alpha,8beta(R*),8Aalpha))-
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-beta,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1alpha(betaS*,DS*),2alpha,6alpha,8beta(R*),8Aalpha))-
  • Mevalotin
  • sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-
  • NSC 759253
  • NSC 759253
  • Pravatatin
  • Liprevil
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,6,7,8,8A-HEXAHYDRO-beta,D,6-TRIHYDROXY-2-METHYL-8-(2-METHYL-1-OXOBUTOXY)-, MONOSODIUM SALT, (1S-(1alpha(betaS*,DS*),2alpha,6alpha,8beta(R*),8Aalpha))-
  • Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
  • Mevalotin
  • Mevalotin
  • Pravastatin (sodium) (Standard)
  • Pravatatin
  • Pravatatin
  • NSC 759253
  • sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
  • Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
  • Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
  • Mevalotin
  • Lipemol
  • Pravastatin (sodium) (Standard)
  • Pravastatin (sodium) (Standard)
  • Pravatatin
  • sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
  • HY-B0165AR
  • sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
  • Lipemol
  • Sodium (+)-(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-beta,delta,6,8-tetrahydroxy-2-methyl-1-naphthaleneheptanoate, 8-((2S)-2-methylbutyrate)
  • PRAVASTATIN SODIUM [USP-RS]
  • Lipemol
  • HY-B0165AR
  • HY-B0165AR
  • Pravastatin (sodium) (Standard)
  • Eptastatin sodium
  • PRAVASTATIN SODIUM [USP-RS]
  • Pravachol (TN)
  • sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
  • PRAVASTATIN SODIUM [USP-RS]
  • Eptastatin sodium
  • 2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
  • Lipemol
  • Eptastatin sodium
  • Pravachol (TN)
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
  • HY-B0165AR
  • Pravachol (TN)
  • 2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
  • Elisor
  • PRAVASTATIN SODIUM [USP-RS]
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
  • 2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
  • MFCD00887601
  • Eptastatin sodium
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
  • Elisor
  • Pravasine
  • Pravachol (TN)
  • Elisor
  • MFCD00887601
  • 2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-
  • MFCD00887601
  • Pravasine
  • (3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoicacid,sodiumsalt
  • Pravasine
  • Elisor
  • MFCD00887601
  • Pravasine
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S-[1α(βS*,δS*),2α,6α,8β(R*),8aα]]- (ZCI)
  • 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, monosodium salt, (βR,δR,1S,2S,6S,8S,8aR)- (9CI)
  • 3β-Hydroxycompactin sodium salt
  • CS 514
  • Mevan
  • Oliprevin
  • Prava
  • Pravastatin sodium salt
  • Pravastin
  • Pravator
  • Selectin
  • Sodium pravastatin
物化性质
实验特性
LogP 2.44040
PSA 124.29000
Merck 7714
沸点 634.5°C at 760 mmHg
熔点 154-160 ºC
蒸气压 No data available
闪点 No data available
溶解度 H2O: 19 mg/mL
颜色与性状 白色至微黄白色粉末或结晶性粉末,无臭,味苦。
溶解性 H2O: 19 mg/mL
敏感性 对热敏感
比旋光度 +153° ~ +160° (c=0.5, H2O)
计算特性
精确分子量 447.23600
氢键供体数量 3
氢键受体数量 7
可旋转化学键数量 11
同位素质量 446.22804773 g/mol
重原子数量 31
复杂度 662
同位素原子数量 0
确定原子立构中心数量 8
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 2
表面电荷 0
拓扑分子极性表面积 127
分子量 446.5
海关数据
海关编码 2932999099
海关数据

中国海关编码:

2932999099

概述:

2932999099. 其他仅含氧杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途

Summary:

2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

相关文献
专业数据库参考
PubChemId 87561232
参考资料
Reaxys RN 4836204
普伐他汀钠推荐生产厂家
960化工网为您提供普伐他汀钠专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:81131-70-6,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等
平台客服 平台客服

平台在线客服